 Northwest News Time, now 6.50. Time for an update on money news. Shares of Morphic Holdings shot up today after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly. The cash deal valued at roughly $3.2 billion. Lilly says the acquisition would improve outcomes for patients with inflammatory bowel disease. Morphic stock jumped more than 76% in pre-market trading. Morphic finished today up 75%, while shares of Lilly grew 0.3%.